The tweet was deleted by the author.
But we saved everything 🙂.
Bitwise has filed for an exchange-traded fund focused on AI drug discovery. James Seyffart described the development on social media and expressed support for such investments, stating that the entire world should be cheering for these efforts to succeed.
View post on X Loading...
James Seyffart has previously commented on ETF developments, including when BlackRock filed for a buffer Bitcoin ETF with downside protection under the ticker PBIT, as reported here. He has also noted that the Roundhill memory ETF DRAM traded near its late July low at about $44.5, with the price recently around $46, according to an earlier observation. These updates highlight Seyffart's continuing focus on activity in the ETF sector.